Arnab Ray, MD
Gastroenterology · New Orleans, LANPI 1922155720
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Ferring Pharmaceuticals Inc. accounts for 96.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $19,050 and has fallen 99.6% since, to $83 in 2024. Among gastroenterology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $747.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$25K
- AbbVie$248
- Takeda Pharmaceuticals U.S.A., Inc.$150
- Gilead$142
- ERBE USA Inc$120
- Pentax Of America, Inc.$111
- plus $170 from 3 others
What the payments were for
- Consulting fees$7,90530%
- Speaking & faculty fees$14,56556%
- Travel & lodging$1,0584%
- Food & beverage$1,4706%
- Education$1,1604%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 22 | $25,218 |
| AbbVie(2 entities) | 3 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $150 |
| Gilead | 2 | $142 |
| ERBE USA Inc | 1 | $120 |
| Pentax Of America, Inc. | 1 | $111 |
| Boston Scientific | 2 | $87 |
| Enterra Medical, Inc. | 2 | $60 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REBYOTA$18,692
- GATTEX$150
- ZENPEP$125
- ERBE$120
- Aloka Arietta 850$111
How this compares
$26,159 in reported general payments places this provider in the 90th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 13 | $402,280 |
| LinzessLinaclotide | 56 | $51,871 |
| MotegrityPrucalopride Succinate | 27 | $30,102 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 87 | $5,869 |
| Sucralfate | 32 | $3,846 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 128 | $2,185 |
| Omeprazole | 125 | $2,006 |
| CholestyramineCholestyramine (With Sugar) | 18 | $1,786 |
| Pantoprazole Sodium | 96 | $1,355 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 64 | $1,185 |
| Dicyclomine Hcl | 58 | $879 |
| Amitriptyline Hcl | 56 | $681 |
| Ondansetron OdtOndansetron | 27 | $676 |
| Mirtazapine | 22 | $642 |
| Promethazine Hcl | 66 | $489 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $248 | $51,87156 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $150 | $30,10227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 254 gastroenterology providers in Louisiana.
Other gastroenterology in New Orleans
- Sarah GloverNew Orleans$274K
- Nisha LoganantharajNew Orleans$173K
- Shamita ShahNew Orleans$114K
- Vivek HuilgolNew Orleans$37K
- Janak ShahNew Orleans$18K
- Stephen LandreneauNew Orleans$17K
- Virendra JoshiNew Orleans$16K
- Parth ParekhNew Orleans$10K
- Jonathon ChapmanBaton Rouge$998K
- Conar FittonKenner$955K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.